SEC Filing Summary: First Light Acquisition Group, Inc. (FLAG)
Business Context and Reporting Period
This Form 8-K was filed on November 11, 2022, by First Light Acquisition Group, Inc. (FLAG), a Special Purpose Acquisition Company (SPAC). The filing reports events occurring on November 14, 2022, regarding the transfer of the company's stock listing. Note: The input metadata references "Calidi Biotherapeutics, Inc.", but the filing text explicitly identifies the registrant as First Light Acquisition Group, Inc.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status changes.
Material Changes
- Listing Transfer: FLAG announced it will voluntarily delist from The New York Stock Exchange (NYSE) and transfer its listing to NYSE American LLC.
- Effective Date: The transfer is anticipated to occur on or about November 17, 2022.
- Securities Affected: The transfer applies to Units (FLAGU), Class A common stock (FLAG), and Redeemable warrants (FLAGW).
Outlook, Risks, and Management Commentary
Management intends to continue filing the same periodic reports and information with the SEC following the transfer. The company plans to file a Form 8-A to register its securities on NYSE American. No specific risks, contingencies, or unusual items were detailed in this specific filing text beyond the listing change.
Investor Verification Checklist
- Verify the exact date of the listing transfer to NYSE American (anticipated November 17, 2022).
- Confirm the new trading symbols and exchange status for Units, Class A shares, and warrants on NYSE American.
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the business combination or SPAC status.
- Check subsequent filings for the Form 8-A registration statement.